BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
57.33
-2.13 (-3.58%)
At close: Aug 8, 2025, 4:00 PM
58.22
+0.89 (1.55%)
After-hours: Aug 8, 2025, 7:56 PM EDT
Despegar.com Analyst Ratings
Total Analysts
23
Consensus Rating
Buy
Price Target
$93.14
Upside
+62.46%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Maintains $101 → $106 | Strong Buy | Maintains | $101 → $106 | +84.89% | Aug 6, 2025 |
UBS | UBS | Strong Buy Maintains $113 → $114 | Strong Buy | Maintains | $113 → $114 | +98.85% | Aug 5, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $97 → $96 | Buy | Maintains | $97 → $96 | +67.45% | Jul 22, 2025 |
JP Morgan | JP Morgan | Buy Maintains $108 → $113 | Buy | Maintains | $108 → $113 | +97.10% | Jul 14, 2025 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $124 → $104 | Strong Buy | Maintains | $124 → $104 | +81.41% | May 5, 2025 |
Citigroup | Citigroup | Hold Maintains $82 → $78 | Hold | Maintains | $82 → $78 | +36.05% | May 2, 2025 |
Oppenheimer | Oppenheimer | Hold → Buy Upgrades $98 | Hold → Buy | Upgrades | $98 | +70.94% | Feb 24, 2025 |
Scotiabank | Scotiabank | Hold Maintains $78 → $80 | Hold | Maintains | $78 → $80 | +39.54% | Feb 20, 2025 |
Citigroup | Citigroup | Hold Maintains $81 → $82 | Hold | Maintains | $81 → $82 | +43.03% | Feb 20, 2025 |
RBC Capital | RBC Capital | Hold Reiterates $70 | Hold | Reiterates | $70 | +22.10% | Feb 20, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $90 | Buy | Reiterates | $90 | +56.99% | Feb 20, 2025 |
UBS | UBS | Strong Buy Maintains $109 → $113 | Strong Buy | Maintains | $109 → $113 | +97.10% | Feb 20, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $122 → $126 | Buy | Maintains | $122 → $126 | +119.78% | Feb 20, 2025 |
B of A Securities | B of A Securities | Strong Buy Maintains $99 → $103 | Strong Buy | Maintains | $99 → $103 | +79.66% | Feb 20, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $90 | Buy | Reiterates | $90 | +56.99% | Dec 12, 2024 |
Wolfe Research | Wolfe Research | Buy Initiates $95 | Buy | Initiates | $95 | +65.71% | Nov 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.